Yunnan Botanee Bio-Technology Group Co Ltd (300957)

Currency in CNY
48.90
-0.90(-1.81%)
Closed·
300957 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
300957 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
48.8949.87
52 wk Range
37.4674.00
Key Statistics
Bid/Ask
48.91 / 48.90
Prev. Close
49.8
Open
49.8
Day's Range
48.89-49.87
52 wk Range
37.46-74
Volume
5.67M
Average Volume (3m)
4.92M
1-Year Change
20.47%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
300957 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
47.79
Downside
-2.27%
Members' Sentiments
Bearish
Bullish
ProTips
Impressive gross profit margins
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Strong Sell
Moving Averages
Neutral

Yunnan Botanee Bio-Technology Group Co Ltd Company Profile

Yunnan Botanee Bio-Technology Group Co.LTD engages in the research and development, production, and sales of cosmetics in China. It operates through Skin Care Products and Medical Instruments segments. The company offers facial creams, lotion, masks, essence, and lotions, as well as makeup products, such as primer, powders, BB creams, and makeup removers. It is also involved in the research, development, production, and sales of medical devices comprising transparent and hyaluronic acid repair biofilm and dressings used for the protection and care of damaged skin barriers after minimally invasive procedures. In addition, the company offers Qiumei App, an AI system for common skin problem. The company offers its products under Winona, Winona Baby, AOXMED, Beforteen, Za, and PURE&MILD brand names through offline and online channels. It offers its products through e-commerce platforms, retail stores, distributors, and entrusted parties. Yunnan Botanee Bio-Technology Group Co.LTD was incorporated in 2010 and is headquartered in Kunming, China.

Compare 300957 to Peers and Sector

Metrics to compare
300957
Peers
Sector
Relationship
P/E Ratio
77.2x37.8x12.2x
PEG Ratio
−1.16−0.620.03
Price/Book
3.4x2.8x1.5x
Price / LTM Sales
3.9x3.5x0.9x
Upside (Analyst Target)
−6.4%6.9%16.5%
Fair Value Upside
Unlock11.1%9.7%Unlock

Analyst Ratings

8 Buy
7 Hold
1 Sell
Ratings:
16 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 47.79
(-2.27% Downside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.63%
Dividend Yield
1.23%
Industry Median 1.32%
Annualised payout
0.60
Paid annually
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Aug 28, 2025
EPS / Forecast
0.52 / 0.69
Revenue / Forecast
1.42B / 1.89B
EPS Revisions
Last 90 days

300957 Income Statement

FAQ

What Stock Exchange Does Yunnan Botanee BioTechnology Group Co Trade On?

Yunnan Botanee BioTechnology Group Co is listed and trades on the Shenzhen Stock Exchange stock exchange.

What Is the Stock Symbol for Yunnan Botanee BioTechnology Group Co?

The stock symbol for Yunnan Botanee BioTechnology Group Co is "300957."

What Is the Yunnan Botanee BioTechnology Group Co Market Cap?

As of today, Yunnan Botanee BioTechnology Group Co market cap is 20.54B.

What Is Yunnan Botanee BioTechnology Group Co's Earnings Per Share (TTM)?

The Yunnan Botanee BioTechnology Group Co EPS (TTM) is 0.63.

When Is the Next Yunnan Botanee BioTechnology Group Co Earnings Date?

Yunnan Botanee BioTechnology Group Co will release its next earnings report on 21 Oct 2025.

From a Technical Analysis Perspective, Is 300957 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Yunnan Botanee BioTechnology Group Co Stock Split?

Yunnan Botanee BioTechnology Group Co has split 0 times.

How Many Employees Does Yunnan Botanee BioTechnology Group Co Have?

Yunnan Botanee BioTechnology Group Co has 3956 employees.

What is the current trading status of Yunnan Botanee BioTechnology Group Co (300957)?

As of 14 Sept 2025, Yunnan Botanee BioTechnology Group Co (300957) is trading at a price of 48.90, with a previous close of 49.80. The stock has fluctuated within a day range of 48.89 to 49.87, while its 52-week range spans from 37.46 to 74.00.

What Is Yunnan Botanee BioTechnology Group Co (300957) Price Target According to Analysts?

The average 12-month price target for Yunnan Botanee BioTechnology Group Co is CNY47.78917, with a high estimate of CNY66 and a low estimate of CNY38. 8 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Buy. The stock has an -2.27% Downside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.